Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19

Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19

Abstract Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with coronavirus disease 2019 (COVID-19) are helpful for understanding the pathology. Using SARS-CoV-2 pseudotyped virus, ser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Miyuki Kimura, Hiroshi Yamada, Yoshihiro Yoshida, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/8beed82176484596aa1bd15d7e9025b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/8beed82176484596aa1bd15d7e9025b1

Ejemplares similares